Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 17, 2011, Pages 7160-7165

  Navab, Roya ^a   Strumpf, Dan ^a   Bandarchi, Bizhan ^a   Zhu, Chang Qi ^a   Pintilie, Melania ^a   Ramnarine, Varune Rohan ^a   Ibrahimov, Emin ^a   Radulovich, Nikolina ^a   Leung, Lisa ^a   Barczyk, Malgorzata ^a,b   Panchal, Devang ^a   To, Christine ^a   Yun, James J ^a   Der, Sandy ^a   Shepherd, Frances A ^a,c   Jurisica, Igor ^a,c,d   Tsao, Ming Sound ^a,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Department of Biomedicine ^*  (Norway)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenocarcinoma; Extracellular matrix; Integrin 11; NAViGaTOR

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA ASSOCIATED FIBROBLAST; CONTROLLED STUDY; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; STROMA; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TRANSFORMED; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 79955562722     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014506108     Document Type: Article

References (37)

1. Jemal A, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
2. Demarchi LM, et al. (2000) Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung. Mod Pathol 13:511-520.
3. Nakamura H, et al. (2003) cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas. Cancer 97:2798-2805. (Pubitemid 36605148)
4. Crawford Y, et al. (2009) PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15:21-34.
5. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54. (Pubitemid 36068681)
6. Finak G, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518-527. (Pubitemid 351655218)
7. Serini G, Gabbiani G (1999) Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250:273-283. (Pubitemid 29367440)
8. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001) α-Smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-2741. (Pubitemid 33051938)
9. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121. (Pubitemid 32397092)
10. Shedden K, et al. (2008) Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma Gene expression-based survival prediction in lung adenocarcinoma: A multi-site, blinded validation study. Nat Med 14:822-827.
11. Zhu CQ, et al. (2010) Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 28:4417-4424.
12. Bild AH, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357. (Pubitemid 43128862)
13. Lee ES, et al. (2008) Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 14:7397-7404.
14. Brown KR, Jurisica I (2007) Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol 8:R95.
15. Brown KR, Jurisica I (2005) Online predicted human interaction database. Bioinformatics 21:2076-2082. (Pubitemid 40668047)
16. Kandasamy K, et al. (2010) NetPath: A public resource of curated signal transduction pathways. Genome Biol 11:R3.
17. Yue X, et al. (2008) Transforming growth factor-β1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem 283:20397-20407.
18. Honda E, Yoshida K, Munakata H (2010) Transforming growth factor-β upregulates the expression of integrin and related proteins in MRC-5 human myofibroblasts. Tohoku J Exp Med 220:319-327.
19. Lu N, et al. (2010) The human α11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-β1 in a Smad- and Sp1-dependent manner. Matrix Biol 29:166-176.
20. Schedin P, O'Brien J, Rudolph M, Stein T, Borges V (2007) Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 12:71-82. (Pubitemid 46394927)
21. Kuhn I, et al. (2001) Identification of AKT-regulated genes in inducible MERAkt cells. Physiol Genomics 7:105-114.
22. Kobie JJ, Akporiayea ET (2003) Immunosuppressive role of transforming growth factor β in breast cancer. Clin Appl Immunol Rev 3:277-287. (Pubitemid 36612141)
23. Lee KB, et al. (2008) Clusterin, a novel modulator of TGF-β signaling, is involved in Smad2/3 stability. Biochem Biophys Res Commun 366:905-909.
24. Pyagay P, et al. (2005) Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 96:261-268. (Pubitemid 40209374)
25. Beer DG, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824.
26. Campbell I, Qiu W, Haviv I (2011) Genetic changes in tumour microenvironments. J Pathol 223:450-458.
27. Zhu CQ, et al. (2007) Integrin α11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. Proc Natl Acad Sci USA 104: 11754-11759.
28. Margadant C, Sonnenberg A (2010) Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97-105.
29. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392-401.
30. Chalifa-Caspi V, et al. (2004) GeneAnnot: Comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. Bioinformatics 20:1457-1458. (Pubitemid 38931417)
31. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
32. Ashburner M, et al. (2000) The Gene Ontology Consortium Gene ontology: Tool for the unification of biology. Nat Genet 25:25-29. (Pubitemid 30257031)
33. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38(Database issue):D355-D360.
34. Matthews L, et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37(Database issue):D619-D622.
35. Gortzak-Uzan L, et al. (2008) A proteome resource of ovarian cancer ascites: Integrated proteomic and bioinformatic analyses to identify putative biomarkers. J Proteome Res 7:339-351. (Pubitemid 351171148)
36. Brown KR, et al. (2009) NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics 25:3327-3329.
37. Littell RC, Henry PR, Ammerman CB (1998) Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76:1216-1231. (Pubitemid 128437870)